HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are living with HIV-1 (a specific type of HIV)
- People who are 18 years of age or older
- People who have been informed about the study and have not objected to taking part
- People who agree to use an electronic pill bottle cap (a device that records when the bottle is opened) to track medication use
- People who are currently taking, or are about to start taking, a specific HIV medication called bictegravir/emtricitabine/tenofovir (also known as B/F/TAF) — this includes people who have never been on HIV treatment before, people switching from a different treatment, or people whose current treatment is no longer controlling the virus
Who may not be able to join:
- People who are pregnant
- People who are living in an institution, or who have a legal guardian, or who have difficulties with judgment or decision-making (as the trial requires participants to independently manage their own treatment)
- People who receive a type of care or assistance that would make it difficult or impossible to use the electronic pill bottle cap
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Laurent HOCQUELOUX, M.D., CHU d'Orléans (France)
Phone: +33 2 38 22 95 88
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of patients with virological failure at 6 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.